Acoustofluidic Pipette for Rapid Serodiagnosis of Candida Infection
用于念珠菌感染快速血清诊断的声流控移液器
基本信息
- 批准号:10388272
- 负责人:
- 金额:$ 19.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-09 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcousticsAddressAmphotericin BAntibioticsAntibodiesAntibody ResponseAntifungal AgentsAntigensAutomationBar CodesBenchmarkingBiological AssayBiological MarkersBiosensing TechniquesBiosensorBloodBlood specimenBuffersCandidaCandida albicansCandida aurisCandidiasisClinicalColorCytolysisDangerousnessDetectionDevelopmentDevicesDiagnosisDiseaseEarly DiagnosisEarly treatmentElasticityElementsEnzyme-Linked Immunosorbent AssayEquationErythrocytesFlow CytometryFluorescenceFluorescent Antibody TechniqueFlushingFructosediphosphate AldolaseFutureGlucansGoalsHealthHistopathologyImmobilizationInfectionLabelLasersLiquid substanceMeasuresMechanicsMethodsMicroscopeMicroscopyModelingMulti-Drug ResistanceMycosesOutcomeParticle SizePatientsPharmaceutical PreparationsPhasePhysiologicalRadiationReaderResearchResistanceResistant candidaRisk FactorsSamplingSensitivity and SpecificitySerodiagnosesSerologySerology testSpecificitySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStainsSystemTechniquesTechnologyTestingTherapeutic InterventionTimeWorkantibody detectionantigen detectionbeta-Glucanscommensal microbescostculture platesdetectordysbiosisenolasefungushead-to-head comparisonimprovedinnovationinstrumentmultiplex assaymultiplex detectionparticleparticle chamberpathogenpoint of carepressureprocessing speedprototypespecific biomarkerstargeted biomarkertoolwasting
项目摘要
ABSTRACT
Invasive fungal diseases (IFDs) represent a large and growing problem in the U.S. Conventional methods for
detecting IFDs include blood culture and histopathology, which require two to three days to complete. As a
precautionary measure, patients are often given broad-spectrum antibiotics, which are ineffective against IFDs
and can damage patients’ commensal microbiota, leading to severe dysbiosis and related health issues. To
address this issue, several serological assays have been proposed to detect antigens or antibody responses in
blood. However, these methods have failed to supplant clinical mainstays due to high cost, complexity, and
most of all, limited sensitivity and/or specificity, especially during the early phases of infection. Our central
hypothesis is that development of a simple and sensitive point-of-care (POC) device that can capture and
purify multiple biomarkers simultaneously will radically improve the value of serodiagnoses. Our broad
objective is to develop a handheld acoustic pipette for the rapid and efficient isolation of fungal biomarkers and
prepare those biomarkers for downstream analysis. The outcome of this exploratory research will be a versatile
prototype for multiplexed serological detections that is amenable to automation. This instrument will be
distinguished from other IFD biosensing technologies through its innovative use of negative acoustic contrast
particles (NACPs). Due to their elasticity, NACPs can immobilize against the pressure antinodes of an acoustic
standing wave. This will allow us to capture specific biomarkers (e.g., antibodies, antigens), acoustically trap
them within the device, and flush blood debris as waste. Then, captured biomarkers will be mixed and labeled
with secondary fluorescent antibodies using microstructured fluidic chambers in a disposable cartridge housed
within the pipette. Once biomarkers have been washed and stained, NACPs will be ejected from the device for
analysis by standard analytical techniques, like microscopy or flow cytometry. We focus on C. albicans as a
model IFD pathogen in this proposal due to its unique and well-characterized biomarkers. We propose three
Specific Aims. Aim 1 will develop an acoustic pipette for rapid NACP mixing, trapping and washing. Aim 2 will
determine the assay sensitivity and specificity for detecting C. albicans biomarkers: anti-Eno antibodies, anti-
Fba1 antibodies and Eno antigens. Aim 3 will develop a multiplexed assay to simultaneously isolate and
distinguish multiple biomarkers for C. albicans using barcoded NACPs. Aim 3 will also extend this multiplexing
concept to screen for L. prolificans, a fungus that is fully resistant to amphotericin B, to inform early treatment
decisions for antifungal medications. If successful, this technology will dramatically shorten the time needed to
isolate and detect biomarkers that may impact not only the diagnosis of candidiasis, but also more lethal and
obscure IFDs in an ergonomic and semi-automated device. Once validated, future work will advance this
prototype to a full POC instrument by the integration of an in-line fluorescence inspection module.
抽象的
侵入性真菌疾病(IFD)代表了美国常规方法的大问题
检测IFD包括血液培养和组织病理学,需要两到三天才能完成。作为
预防性测量,患者通常会被给予广谱抗生素,而对IFD的无效
并可能损害患者的共生微生物群,导致严重的营养不良和相关的健康问题。到
解决这个问题,已经提出了几种血清学测定法以检测抗原或抗体反应
血。但是,由于成本高,复杂性和
最重要的是,敏感性和/或特异性有限,尤其是在感染的早期阶段。我们的中心
假设是可以捕获和
纯化多种生物标志物将根本上提高血清诊断的价值。我们的广阔
目的是开发一个手持式声学移液器,以快速有效地隔离真菌生物标志物和
准备这些生物标志物进行下游分析。这项探索性研究的结果将是一种多功能
多重血清学检测的原型,可自动化。这个乐器将是
与其他IFD生物传感技术通过创新使用负面的对比度区别
颗粒(NACP)。由于其弹性,NACP可以固定在声学的压力抗in
站立波。这将使我们能够捕获特定的生物标志物(例如抗体,抗原),声学陷阱
它们在设备中,将血液碎屑作为废物冲洗。然后,将捕获的生物标志物被混合并标记
使用微结构的液体室与一次性弹药筒中的二级荧光抗体一起使用
在移液器中。一旦将生物标志物洗涤并染色,NACP将从设备中弹出
通过标准分析技术进行分析,例如显微镜或流式细胞仪。我们专注于白色念珠菌作为
由于其独特且特征良好的生物标志物,该提案中的IFD病原体模型。我们提出了三个
具体目标。 AIM 1将开发一种声学移液器,用于快速的NACP混合,捕获和洗涤。 AIM 2意志
确定检测白色念珠菌生物标志物的敏感性和特异性:抗Eno抗体,抗体
FBA1抗体和ENO抗原。 AIM 3将开发多重测定法以同时隔离和
使用条形码的NACP的白色念珠菌的独特多个生物标志物。 AIM 3还将扩展此多路复用
筛选L. prourificans(一种对两性霉素B具有抗性的真菌)的概念,以告知早期治疗
抗真菌药物的决定。如果成功,这项技术将大大缩短
分离和检测生物标志物不仅可能影响念珠菌病的诊断,而且还会影响更大的致命性和
符合人体工程学和半自动化设备中的IFD。一旦得到验证,未来的工作将推进
通过在线荧光检查模块的整合到完整POC仪器的原型。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Magnetically locked Janus particle clusters with orientation-dependent motion in AC electric fields.
磁锁 Janus 粒子簇在交流电场中具有方向相关的运动。
- DOI:10.1039/d3nr03744d
- 发表时间:2023
- 期刊:
- 影响因子:6.7
- 作者:Lee,JinGyun;Thome,CooperP;Cruse,ZoeA;Ganguly,Arkava;Gupta,Ankur;Shields4th,CWyatt
- 通讯作者:Shields4th,CWyatt
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Wyatt Shields IV其他文献
Charles Wyatt Shields IV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Wyatt Shields IV', 18)}}的其他基金
Adoptive Macrophage Transfers for Nanoparticle Delivery
用于纳米颗粒递送的过继巨噬细胞转移
- 批准号:
10501313 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Adoptive Macrophage Transfers for Nanoparticle Delivery
用于纳米颗粒递送的过继巨噬细胞转移
- 批准号:
10794553 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Adoptive Macrophage Transfers for Nanoparticle Delivery
用于纳米颗粒递送的过继巨噬细胞转移
- 批准号:
10688187 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
- 批准号:
10643423 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
- 批准号:
10693593 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Antifungals targeting pantothenate phosphorylation
靶向泛酸磷酸化的抗真菌药
- 批准号:
10696567 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
- 批准号:
10759723 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别: